We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+2.78%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.84B
AUM Growth
-$535M
Cap. Flow
-$207M
Cap. Flow %
-3.54%
Top 10 Hldgs %
25.28%
Holding
175
New
17
Increased
89
Reduced
33
Closed
14

Top Buys

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$43.8M
2
NXT icon
Nextpower Inc
NXT
+$38.9M
3
NTNX icon
Nutanix
NTNX
+$36.8M
4
PWR icon
Quanta Services
PWR
+$33.4M
5
EVH icon
Evolent Health
EVH
+$28M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$165M
2
COUR icon
Coursera
COUR
+$63.3M
3
SPT icon
Sprout Social
SPT
+$57.1M
4
DLO icon
dLocal
DLO
+$49.4M
5
MDB icon
MongoDB
MDB
+$42.1M

Sector Composition

Rank Sector Weight
1 Healthcare 37.83%
2 Technology 24.9%
3 Industrials 17.52%
4 Consumer Discretionary 8.37%
5 Communication Services 2.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INSP icon
101
Inspire Medical Systems
INSP
$1.44B
$16.7M 0.29%
125,090
– –
RCKT icon
102
Rocket Pharmaceuticals
RCKT
$351M
$16.6M 0.28%
770,691
+279,959
+57% +$6.43M
MSCI icon
103
MSCI
MSCI
$41.9B
$16M 0.27%
33,275
-45,934
-58% -$22.8M
AIT icon
104
Applied Industrial Technologies
AIT
$12.6B
$15.6M 0.27%
80,493
+28,198
+54% +$5.38M
RELY icon
105
Remitly
RELY
$4.94B
$15.4M 0.26%
1,267,115
+238,437
+23% +$3.7M
RNAM
106
DELISTED
Avidity Biosciences
RNAM
$15.4M 0.26%
+375,924
New +$10.8M
RGEN icon
107
Repligen
RGEN
$7.03B
$15M 0.26%
119,000
– –
IP icon
108
International Paper
IP
$22.8B
$14.6M 0.25%
+339,397
New +$13.8M
ANAB icon
109
AnaptysBio
ANAB
$1.63B
$14.2M 0.24%
568,324
+141,324
+33% +$3.29M
KYMR icon
110
Kymera Therapeutics
KYMR
$8.8B
$13.8M 0.24%
462,099
+442,325
+2,237% +$15.3M
CYTK icon
111
Cytokinetics
CYTK
$10.9B
$13.8M 0.24%
254,148
– –
IEX icon
112
IDEX
IEX
$17.3B
$13.5M 0.23%
67,007
+313
+0.5% +$68.4K
VKTX icon
113
Viking Therapeutics
VKTX
$3.84B
$13.4M 0.23%
252,969
– –
TGTX icon
114
TG Therapeutics
TGTX
$8.19B
$12.8M 0.22%
718,814
– –
FSLR icon
115
First Solar
FSLR
$22.1B
$12.5M 0.21%
+55,399
New +$12.1M
VCYT icon
116
Veracyte
VCYT
$4.77B
$12.2M 0.21%
564,000
– –
GPI icon
117
Group 1 Automotive
GPI
$3.53B
$12.2M 0.21%
41,088
+7,894
+24% +$2.34M
ARWR icon
118
Arrowhead Research
ARWR
$12.3B
$12.1M 0.21%
463,894
+150,605
+48% +$3.7M
COGT icon
119
Cogent Biosciences
COGT
$7.07B
$11.8M 0.2%
+1,398,992
New +$10.6M
IDYA icon
120
IDEAYA Biosciences
IDYA
$3.5B
$11.8M 0.2%
335,000
– –
CTRA
121
DELISTED
Coterra Energy
CTRA
$11.2M 0.19%
+418,685
New +$11.6M
GXO icon
122
GXO Logistics
GXO
$5.8B
$11.2M 0.19%
220,834
+84
+0% +$4.24K
CEG icon
123
Constellation Energy
CEG
$94.1B
$11.1M 0.19%
55,636
-6,857
-11% -$1.4M
CBT icon
124
Cabot Corp
CBT
$4.55B
$9.42M 0.16%
102,547
+388
+0.4% +$37.6K
NKTR icon
125
Nektar Therapeutics
NKTR
$2.41B
$9.34M 0.16%
+501,940
New +$10.6M
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Eventide Asset Management held 175 positions worth $5.84B, down 8.4% from $6.38B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $207M in Q2 2024, closing 14 positions and reducing 33 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $165M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Nextpower Inc worth $36.6M.

  • Eventide Asset Management's largest Q2 2024 buy was Nextpower Inc: 781,302 shares worth $36.6M.
  • Eventide Asset Management added most to Axsome Therapeutics in Q2 2024, an estimated $43.8M increase.
  • Eventide Asset Management's biggest Q2 2024 reduction was MongoDB, cutting an estimated $42.1M.
  • Eventide Asset Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.84B portfolio in Q2 2024.
  • Eventide Asset Management opened 17 new positions and closed 14 in Q2 2024.
  • Eventide Asset Management's portfolio value fell 8.4% quarter-over-quarter to $5.84B.

Based on Eventide Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.